nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—ABCB1—esophageal cancer	0.416	1	CbGaD
Midazolam—Clonus—Cisplatin—esophageal cancer	0.0169	0.0952	CcSEcCtD
Midazolam—Phlebitis—Carboplatin—esophageal cancer	0.00561	0.0315	CcSEcCtD
Midazolam—Skin necrosis—Cisplatin—esophageal cancer	0.00559	0.0314	CcSEcCtD
Midazolam—Obstructive airways disorder—Methotrexate—esophageal cancer	0.00472	0.0265	CcSEcCtD
Midazolam—Slurred speech—Cisplatin—esophageal cancer	0.00437	0.0245	CcSEcCtD
Midazolam—Depressed mood—Capecitabine—esophageal cancer	0.00322	0.0181	CcSEcCtD
Midazolam—Skin necrosis—Methotrexate—esophageal cancer	0.00307	0.0172	CcSEcCtD
Midazolam—Sneezing—Capecitabine—esophageal cancer	0.0026	0.0146	CcSEcCtD
Midazolam—Rhinorrhoea—Cisplatin—esophageal cancer	0.00241	0.0135	CcSEcCtD
Midazolam—Haematoma—Capecitabine—esophageal cancer	0.00229	0.0129	CcSEcCtD
Midazolam—Tenderness—Cisplatin—esophageal cancer	0.00224	0.0126	CcSEcCtD
Midazolam—Dysarthria—Cisplatin—esophageal cancer	0.00206	0.0116	CcSEcCtD
Midazolam—Thrombosis—Capecitabine—esophageal cancer	0.00203	0.0114	CcSEcCtD
Midazolam—Pain—Carboplatin—esophageal cancer	0.00203	0.0114	CcSEcCtD
Midazolam—Hiccups—Cisplatin—esophageal cancer	0.00195	0.011	CcSEcCtD
Midazolam—Wheezing—Cisplatin—esophageal cancer	0.0019	0.0107	CcSEcCtD
Midazolam—Skin exfoliation—Cisplatin—esophageal cancer	0.00186	0.0105	CcSEcCtD
Midazolam—Multiple fractures—Methotrexate—esophageal cancer	0.00184	0.0104	CcSEcCtD
Midazolam—Fracture—Methotrexate—esophageal cancer	0.00184	0.0104	CcSEcCtD
Midazolam—Rhinorrhoea—Capecitabine—esophageal cancer	0.00178	0.00998	CcSEcCtD
Midazolam—Injection site pain—Capecitabine—esophageal cancer	0.00176	0.0099	CcSEcCtD
Midazolam—Dysphonia—Capecitabine—esophageal cancer	0.00175	0.00983	CcSEcCtD
Midazolam—Extrasystoles—Capecitabine—esophageal cancer	0.00171	0.00961	CcSEcCtD
Midazolam—Hypoxia—Methotrexate—esophageal cancer	0.00169	0.00948	CcSEcCtD
Midazolam—Phlebitis—Cisplatin—esophageal cancer	0.00165	0.00924	CcSEcCtD
Midazolam—Musculoskeletal stiffness—Capecitabine—esophageal cancer	0.0016	0.00901	CcSEcCtD
Midazolam—Ventricular extrasystoles—Capecitabine—esophageal cancer	0.00159	0.00895	CcSEcCtD
Midazolam—CYP4B1—bronchus—esophageal cancer	0.00153	0.0899	CbGeAlD
Midazolam—Dysarthria—Capecitabine—esophageal cancer	0.00152	0.00855	CcSEcCtD
Midazolam—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00146	0.00823	CcSEcCtD
Midazolam—Hiccups—Capecitabine—esophageal cancer	0.00144	0.00809	CcSEcCtD
Midazolam—Depressed level of consciousness—Capecitabine—esophageal cancer	0.00139	0.00781	CcSEcCtD
Midazolam—Skin exfoliation—Capecitabine—esophageal cancer	0.00137	0.00772	CcSEcCtD
Midazolam—CYP4B1—trachea—esophageal cancer	0.00137	0.0807	CbGeAlD
Midazolam—Irritability—Cisplatin—esophageal cancer	0.00135	0.0076	CcSEcCtD
Midazolam—GABRA3—neck—esophageal cancer	0.00133	0.078	CbGeAlD
Midazolam—Nasopharyngitis—Cisplatin—esophageal cancer	0.00127	0.00712	CcSEcCtD
Midazolam—Apnoea—Methotrexate—esophageal cancer	0.00126	0.0071	CcSEcCtD
Midazolam—Phlebitis—Capecitabine—esophageal cancer	0.00121	0.00681	CcSEcCtD
Midazolam—Thrombophlebitis—Capecitabine—esophageal cancer	0.00121	0.00678	CcSEcCtD
Midazolam—Sleep disorder—Capecitabine—esophageal cancer	0.00121	0.00678	CcSEcCtD
Midazolam—UGT1A4—digestive system—esophageal cancer	0.0012	0.0703	CbGeAlD
Midazolam—Musculoskeletal stiffness—Methotrexate—esophageal cancer	0.00119	0.00671	CcSEcCtD
Midazolam—Swelling—Capecitabine—esophageal cancer	0.00118	0.00665	CcSEcCtD
Midazolam—CYP4B1—digestive system—esophageal cancer	0.00118	0.0694	CbGeAlD
Midazolam—Dysarthria—Methotrexate—esophageal cancer	0.00113	0.00636	CcSEcCtD
Midazolam—Respiratory failure—Methotrexate—esophageal cancer	0.00109	0.00613	CcSEcCtD
Midazolam—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00107	0.00602	CcSEcCtD
Midazolam—Cardiac failure—Capecitabine—esophageal cancer	0.00107	0.00601	CcSEcCtD
Midazolam—Lethargy—Capecitabine—esophageal cancer	0.00107	0.00599	CcSEcCtD
Midazolam—Diplopia—Capecitabine—esophageal cancer	0.00104	0.00587	CcSEcCtD
Midazolam—Osteoarthritis—Capecitabine—esophageal cancer	0.00104	0.00587	CcSEcCtD
Midazolam—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00103	0.00581	CcSEcCtD
Midazolam—Skin exfoliation—Methotrexate—esophageal cancer	0.00102	0.00575	CcSEcCtD
Midazolam—Bradycardia—Cisplatin—esophageal cancer	0.000998	0.00561	CcSEcCtD
Midazolam—Irritability—Capecitabine—esophageal cancer	0.000997	0.0056	CcSEcCtD
Midazolam—Cardiac arrest—Capecitabine—esophageal cancer	0.000993	0.00558	CcSEcCtD
Midazolam—Mood swings—Capecitabine—esophageal cancer	0.00099	0.00556	CcSEcCtD
Midazolam—CYP4B1—lung—esophageal cancer	0.000986	0.058	CbGeAlD
Midazolam—Ataxia—Capecitabine—esophageal cancer	0.000982	0.00552	CcSEcCtD
Midazolam—Connective tissue disorder—Cisplatin—esophageal cancer	0.000963	0.00541	CcSEcCtD
Midazolam—Visual impairment—Cisplatin—esophageal cancer	0.000945	0.00531	CcSEcCtD
Midazolam—Nasopharyngitis—Capecitabine—esophageal cancer	0.000934	0.00525	CcSEcCtD
Midazolam—Muscular weakness—Capecitabine—esophageal cancer	0.000921	0.00518	CcSEcCtD
Midazolam—Eye disorder—Cisplatin—esophageal cancer	0.000916	0.00515	CcSEcCtD
Midazolam—Cardiac disorder—Cisplatin—esophageal cancer	0.00091	0.00511	CcSEcCtD
Midazolam—Thrombophlebitis—Methotrexate—esophageal cancer	0.000898	0.00505	CcSEcCtD
Midazolam—Bronchospasm—Capecitabine—esophageal cancer	0.000888	0.00499	CcSEcCtD
Midazolam—Immune system disorder—Cisplatin—esophageal cancer	0.000886	0.00498	CcSEcCtD
Midazolam—Mediastinal disorder—Cisplatin—esophageal cancer	0.000884	0.00496	CcSEcCtD
Midazolam—GABRP—bronchus—esophageal cancer	0.000861	0.0506	CbGeAlD
Midazolam—Erythema—Cisplatin—esophageal cancer	0.000853	0.0048	CcSEcCtD
Midazolam—Visual disturbance—Methotrexate—esophageal cancer	0.000821	0.00461	CcSEcCtD
Midazolam—Vision blurred—Cisplatin—esophageal cancer	0.000804	0.00452	CcSEcCtD
Midazolam—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000804	0.00451	CcSEcCtD
Midazolam—Depression—Capecitabine—esophageal cancer	0.000803	0.00451	CcSEcCtD
Midazolam—Tremor—Cisplatin—esophageal cancer	0.0008	0.00449	CcSEcCtD
Midazolam—Lethargy—Methotrexate—esophageal cancer	0.000794	0.00446	CcSEcCtD
Midazolam—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000789	0.00443	CcSEcCtD
Midazolam—Osteoarthritis—Methotrexate—esophageal cancer	0.000778	0.00437	CcSEcCtD
Midazolam—GABRP—trachea—esophageal cancer	0.000773	0.0454	CbGeAlD
Midazolam—Irritability—Methotrexate—esophageal cancer	0.000742	0.00417	CcSEcCtD
Midazolam—Mood swings—Methotrexate—esophageal cancer	0.000737	0.00414	CcSEcCtD
Midazolam—Bradycardia—Capecitabine—esophageal cancer	0.000736	0.00413	CcSEcCtD
Midazolam—Ataxia—Methotrexate—esophageal cancer	0.000731	0.00411	CcSEcCtD
Midazolam—Anxiety—Cisplatin—esophageal cancer	0.000724	0.00407	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000722	0.00405	CcSEcCtD
Midazolam—Connective tissue disorder—Capecitabine—esophageal cancer	0.00071	0.00399	CcSEcCtD
Midazolam—Anaphylactic shock—Cisplatin—esophageal cancer	0.000697	0.00391	CcSEcCtD
Midazolam—Visual impairment—Capecitabine—esophageal cancer	0.000696	0.00391	CcSEcCtD
Midazolam—Nervous system disorder—Cisplatin—esophageal cancer	0.000683	0.00384	CcSEcCtD
Midazolam—Tachycardia—Cisplatin—esophageal cancer	0.00068	0.00382	CcSEcCtD
Midazolam—Skin disorder—Cisplatin—esophageal cancer	0.000677	0.0038	CcSEcCtD
Midazolam—Eye disorder—Capecitabine—esophageal cancer	0.000675	0.00379	CcSEcCtD
Midazolam—CYP4B1—lymph node—esophageal cancer	0.000675	0.0396	CbGeAlD
Midazolam—Cardiac disorder—Capecitabine—esophageal cancer	0.000671	0.00377	CcSEcCtD
Midazolam—GABRE—bronchus—esophageal cancer	0.000657	0.0386	CbGeAlD
Midazolam—Immune system disorder—Capecitabine—esophageal cancer	0.000653	0.00367	CcSEcCtD
Midazolam—Mediastinal disorder—Capecitabine—esophageal cancer	0.000651	0.00366	CcSEcCtD
Midazolam—Hypotension—Cisplatin—esophageal cancer	0.000651	0.00366	CcSEcCtD
Midazolam—Chills—Capecitabine—esophageal cancer	0.000648	0.00364	CcSEcCtD
Midazolam—Mental disorder—Capecitabine—esophageal cancer	0.000633	0.00356	CcSEcCtD
Midazolam—Erythema—Capecitabine—esophageal cancer	0.000629	0.00353	CcSEcCtD
Midazolam—Paraesthesia—Cisplatin—esophageal cancer	0.000625	0.00351	CcSEcCtD
Midazolam—Dyspnoea—Cisplatin—esophageal cancer	0.000621	0.00349	CcSEcCtD
Midazolam—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000601	0.00338	CcSEcCtD
Midazolam—Drowsiness—Methotrexate—esophageal cancer	0.000599	0.00337	CcSEcCtD
Midazolam—Depression—Methotrexate—esophageal cancer	0.000598	0.00336	CcSEcCtD
Midazolam—Pain—Cisplatin—esophageal cancer	0.000596	0.00335	CcSEcCtD
Midazolam—Vision blurred—Capecitabine—esophageal cancer	0.000593	0.00333	CcSEcCtD
Midazolam—GABRE—trachea—esophageal cancer	0.00059	0.0347	CbGeAlD
Midazolam—Tremor—Capecitabine—esophageal cancer	0.000589	0.00331	CcSEcCtD
Midazolam—Flunitrazepam—CYP2A6—esophageal cancer	0.000583	0.242	CrCbGaD
Midazolam—Feeling abnormal—Cisplatin—esophageal cancer	0.000574	0.00323	CcSEcCtD
Midazolam—Vertigo—Capecitabine—esophageal cancer	0.000565	0.00318	CcSEcCtD
Midazolam—Syncope—Capecitabine—esophageal cancer	0.000564	0.00317	CcSEcCtD
Midazolam—GABRP—lung—esophageal cancer	0.000555	0.0326	CbGeAlD
Midazolam—Cough—Capecitabine—esophageal cancer	0.000549	0.00308	CcSEcCtD
Midazolam—GABRR2—lymph node—esophageal cancer	0.000543	0.0319	CbGeAlD
Midazolam—Anxiety—Capecitabine—esophageal cancer	0.000534	0.003	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000532	0.00299	CcSEcCtD
Midazolam—Dry mouth—Capecitabine—esophageal cancer	0.000524	0.00294	CcSEcCtD
Midazolam—Visual impairment—Methotrexate—esophageal cancer	0.000518	0.00291	CcSEcCtD
Midazolam—Confusional state—Capecitabine—esophageal cancer	0.000518	0.00291	CcSEcCtD
Midazolam—Hypersensitivity—Cisplatin—esophageal cancer	0.000513	0.00288	CcSEcCtD
Midazolam—Shock—Capecitabine—esophageal cancer	0.000505	0.00284	CcSEcCtD
Midazolam—Nervous system disorder—Capecitabine—esophageal cancer	0.000504	0.00283	CcSEcCtD
Midazolam—Eye disorder—Methotrexate—esophageal cancer	0.000503	0.00283	CcSEcCtD
Midazolam—Tachycardia—Capecitabine—esophageal cancer	0.000501	0.00282	CcSEcCtD
Midazolam—Asthenia—Cisplatin—esophageal cancer	0.0005	0.00281	CcSEcCtD
Midazolam—Cardiac disorder—Methotrexate—esophageal cancer	0.000499	0.00281	CcSEcCtD
Midazolam—Skin disorder—Capecitabine—esophageal cancer	0.000499	0.0028	CcSEcCtD
Midazolam—Immune system disorder—Methotrexate—esophageal cancer	0.000486	0.00273	CcSEcCtD
Midazolam—Mediastinal disorder—Methotrexate—esophageal cancer	0.000485	0.00272	CcSEcCtD
Midazolam—Chills—Methotrexate—esophageal cancer	0.000483	0.00271	CcSEcCtD
Midazolam—Hypotension—Capecitabine—esophageal cancer	0.00048	0.0027	CcSEcCtD
Midazolam—Mental disorder—Methotrexate—esophageal cancer	0.000471	0.00265	CcSEcCtD
Midazolam—Erythema—Methotrexate—esophageal cancer	0.000468	0.00263	CcSEcCtD
Midazolam—Flurazepam—CYP2A6—esophageal cancer	0.000468	0.194	CrCbGaD
Midazolam—GABRB2—lung—esophageal cancer	0.000468	0.0275	CbGeAlD
Midazolam—Paraesthesia—Capecitabine—esophageal cancer	0.000461	0.00259	CcSEcCtD
Midazolam—Dyspnoea—Capecitabine—esophageal cancer	0.000458	0.00257	CcSEcCtD
Midazolam—Dyspepsia—Capecitabine—esophageal cancer	0.000452	0.00254	CcSEcCtD
Midazolam—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000443	0.00249	CcSEcCtD
Midazolam—Vomiting—Cisplatin—esophageal cancer	0.000443	0.00249	CcSEcCtD
Midazolam—Fatigue—Capecitabine—esophageal cancer	0.000443	0.00249	CcSEcCtD
Midazolam—Vision blurred—Methotrexate—esophageal cancer	0.000441	0.00248	CcSEcCtD
Midazolam—Rash—Cisplatin—esophageal cancer	0.000439	0.00247	CcSEcCtD
Midazolam—Constipation—Capecitabine—esophageal cancer	0.000439	0.00247	CcSEcCtD
Midazolam—Pain—Capecitabine—esophageal cancer	0.000439	0.00247	CcSEcCtD
Midazolam—Dermatitis—Cisplatin—esophageal cancer	0.000439	0.00247	CcSEcCtD
Midazolam—GABRE—lung—esophageal cancer	0.000424	0.0249	CbGeAlD
Midazolam—Feeling abnormal—Capecitabine—esophageal cancer	0.000423	0.00238	CcSEcCtD
Midazolam—Vertigo—Methotrexate—esophageal cancer	0.000421	0.00236	CcSEcCtD
Midazolam—Nausea—Cisplatin—esophageal cancer	0.000414	0.00232	CcSEcCtD
Midazolam—Cough—Methotrexate—esophageal cancer	0.000409	0.0023	CcSEcCtD
Midazolam—Urticaria—Capecitabine—esophageal cancer	0.000408	0.00229	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000396	0.00222	CcSEcCtD
Midazolam—Confusional state—Methotrexate—esophageal cancer	0.000385	0.00217	CcSEcCtD
Midazolam—Anaphylactic shock—Methotrexate—esophageal cancer	0.000382	0.00215	CcSEcCtD
Midazolam—Hypersensitivity—Capecitabine—esophageal cancer	0.000378	0.00213	CcSEcCtD
Midazolam—CYP2B6—bronchus—esophageal cancer	0.000378	0.0222	CbGeAlD
Midazolam—Nervous system disorder—Methotrexate—esophageal cancer	0.000375	0.00211	CcSEcCtD
Midazolam—Skin disorder—Methotrexate—esophageal cancer	0.000371	0.00209	CcSEcCtD
Midazolam—Asthenia—Capecitabine—esophageal cancer	0.000368	0.00207	CcSEcCtD
Midazolam—Pruritus—Capecitabine—esophageal cancer	0.000363	0.00204	CcSEcCtD
Midazolam—GABRB3—lung—esophageal cancer	0.000359	0.0211	CbGeAlD
Midazolam—Hypotension—Methotrexate—esophageal cancer	0.000357	0.00201	CcSEcCtD
Midazolam—Paraesthesia—Methotrexate—esophageal cancer	0.000343	0.00193	CcSEcCtD
Midazolam—Dyspnoea—Methotrexate—esophageal cancer	0.000341	0.00191	CcSEcCtD
Midazolam—Somnolence—Methotrexate—esophageal cancer	0.00034	0.00191	CcSEcCtD
Midazolam—Dizziness—Capecitabine—esophageal cancer	0.00034	0.00191	CcSEcCtD
Midazolam—Dyspepsia—Methotrexate—esophageal cancer	0.000336	0.00189	CcSEcCtD
Midazolam—Ketazolam—ABCB1—esophageal cancer	0.000336	0.139	CrCbGaD
Midazolam—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00033	0.00185	CcSEcCtD
Midazolam—Fatigue—Methotrexate—esophageal cancer	0.00033	0.00185	CcSEcCtD
Midazolam—Pain—Methotrexate—esophageal cancer	0.000327	0.00184	CcSEcCtD
Midazolam—Vomiting—Capecitabine—esophageal cancer	0.000326	0.00183	CcSEcCtD
Midazolam—Rash—Capecitabine—esophageal cancer	0.000324	0.00182	CcSEcCtD
Midazolam—Dermatitis—Capecitabine—esophageal cancer	0.000323	0.00182	CcSEcCtD
Midazolam—Headache—Capecitabine—esophageal cancer	0.000322	0.00181	CcSEcCtD
Midazolam—Feeling abnormal—Methotrexate—esophageal cancer	0.000315	0.00177	CcSEcCtD
Midazolam—Nausea—Capecitabine—esophageal cancer	0.000305	0.00171	CcSEcCtD
Midazolam—Urticaria—Methotrexate—esophageal cancer	0.000304	0.00171	CcSEcCtD
Midazolam—CYP3A5—digestive system—esophageal cancer	0.000293	0.0172	CbGeAlD
Midazolam—GABRA2—lymph node—esophageal cancer	0.000292	0.0172	CbGeAlD
Midazolam—CYP2B6—digestive system—esophageal cancer	0.000292	0.0171	CbGeAlD
Midazolam—GABRE—lymph node—esophageal cancer	0.00029	0.017	CbGeAlD
Midazolam—Diazepam—PTGS1—esophageal cancer	0.000285	0.118	CrCbGaD
Midazolam—Hypersensitivity—Methotrexate—esophageal cancer	0.000282	0.00158	CcSEcCtD
Midazolam—Asthenia—Methotrexate—esophageal cancer	0.000274	0.00154	CcSEcCtD
Midazolam—CYP2E1—digestive system—esophageal cancer	0.000274	0.0161	CbGeAlD
Midazolam—Pruritus—Methotrexate—esophageal cancer	0.00027	0.00152	CcSEcCtD
Midazolam—Dizziness—Methotrexate—esophageal cancer	0.000253	0.00142	CcSEcCtD
Midazolam—CYP3A5—lung—esophageal cancer	0.000245	0.0144	CbGeAlD
Midazolam—CYP2B6—lung—esophageal cancer	0.000244	0.0143	CbGeAlD
Midazolam—Vomiting—Methotrexate—esophageal cancer	0.000243	0.00137	CcSEcCtD
Midazolam—Rash—Methotrexate—esophageal cancer	0.000241	0.00135	CcSEcCtD
Midazolam—Dermatitis—Methotrexate—esophageal cancer	0.000241	0.00135	CcSEcCtD
Midazolam—Headache—Methotrexate—esophageal cancer	0.000239	0.00135	CcSEcCtD
Midazolam—Clobazam—ABCB1—esophageal cancer	0.000237	0.0985	CrCbGaD
Midazolam—CYP2E1—lung—esophageal cancer	0.000229	0.0134	CbGeAlD
Midazolam—Nausea—Methotrexate—esophageal cancer	0.000227	0.00128	CcSEcCtD
Midazolam—CYP3A4—digestive system—esophageal cancer	0.00022	0.0129	CbGeAlD
Midazolam—ABCB1—epithelium—esophageal cancer	0.000205	0.012	CbGeAlD
Midazolam—Chlorprothixene—ABCB1—esophageal cancer	0.000187	0.0775	CrCbGaD
Midazolam—ABCB1—trachea—esophageal cancer	0.000181	0.0107	CbGeAlD
Midazolam—Flurazepam—ABCB1—esophageal cancer	0.000174	0.0724	CrCbGaD
Midazolam—ABCB1—digestive system—esophageal cancer	0.000156	0.00916	CbGeAlD
Midazolam—Diazepam—ABCB1—esophageal cancer	0.000138	0.0575	CrCbGaD
Midazolam—ABCB1—lung—esophageal cancer	0.00013	0.00765	CbGeAlD
Midazolam—ABCB1—lymph node—esophageal cancer	8.9e-05	0.00523	CbGeAlD
Midazolam—CYP2B6—Metabolism—SLC10A2—esophageal cancer	6.22e-05	0.000161	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	6.18e-05	0.00016	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	6.1e-05	0.000158	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—CREBBP—esophageal cancer	6.1e-05	0.000158	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CA1—esophageal cancer	6.09e-05	0.000157	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SLC10A2—esophageal cancer	6.09e-05	0.000157	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CA1—esophageal cancer	6.08e-05	0.000157	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SLC10A2—esophageal cancer	6.08e-05	0.000157	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	6.05e-05	0.000156	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—TYMP—esophageal cancer	5.99e-05	0.000155	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—HMOX1—esophageal cancer	5.94e-05	0.000154	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.92e-05	0.000153	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.85e-05	0.000151	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ADH1B—esophageal cancer	5.83e-05	0.000151	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP26A1—esophageal cancer	5.83e-05	0.000151	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ABCB1—esophageal cancer	5.71e-05	0.000148	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.71e-05	0.000148	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CA2—esophageal cancer	5.69e-05	0.000147	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ALOX15—esophageal cancer	5.68e-05	0.000147	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—TYMP—esophageal cancer	5.57e-05	0.000144	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CA2—esophageal cancer	5.57e-05	0.000144	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CA2—esophageal cancer	5.56e-05	0.000144	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	5.49e-05	0.000142	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.48e-05	0.000142	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—NOS3—esophageal cancer	5.46e-05	0.000141	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	5.43e-05	0.00014	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP26A1—esophageal cancer	5.42e-05	0.00014	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—TPI1—esophageal cancer	5.42e-05	0.00014	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTO1—esophageal cancer	5.42e-05	0.00014	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	5.4e-05	0.00014	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—BLVRB—esophageal cancer	5.39e-05	0.000139	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SLC52A3—esophageal cancer	5.39e-05	0.000139	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.35e-05	0.000138	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ADH7—esophageal cancer	5.29e-05	0.000137	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PLCE1—esophageal cancer	5.29e-05	0.000137	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ALOX15—esophageal cancer	5.28e-05	0.000137	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.2e-05	0.000134	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ALDOB—esophageal cancer	5.19e-05	0.000134	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ADH7—esophageal cancer	5.18e-05	0.000134	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PLCE1—esophageal cancer	5.18e-05	0.000134	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ADH7—esophageal cancer	5.17e-05	0.000134	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PLCE1—esophageal cancer	5.17e-05	0.000134	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.1e-05	0.000132	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTO1—esophageal cancer	5.04e-05	0.00013	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—TPI1—esophageal cancer	5.04e-05	0.00013	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.02e-05	0.00013	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GAPDH—esophageal cancer	5e-05	0.000129	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PTGS2—esophageal cancer	4.99e-05	0.000129	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.98e-05	0.000129	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CRABP1—esophageal cancer	4.95e-05	0.000128	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.89e-05	0.000127	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ALDOB—esophageal cancer	4.83e-05	0.000125	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GNG7—esophageal cancer	4.71e-05	0.000122	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	4.66e-05	0.00012	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GAPDH—esophageal cancer	4.65e-05	0.00012	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ADH1B—esophageal cancer	4.64e-05	0.00012	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CRABP1—esophageal cancer	4.61e-05	0.000119	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SLC10A2—esophageal cancer	4.59e-05	0.000119	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CA1—esophageal cancer	4.59e-05	0.000119	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ADH1B—esophageal cancer	4.54e-05	0.000117	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ADH1B—esophageal cancer	4.53e-05	0.000117	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	4.52e-05	0.000117	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TYMP—esophageal cancer	4.43e-05	0.000115	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	4.42e-05	0.000114	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ALDH2—esophageal cancer	4.42e-05	0.000114	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GNG7—esophageal cancer	4.39e-05	0.000113	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TYMP—esophageal cancer	4.34e-05	0.000112	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TYMP—esophageal cancer	4.33e-05	0.000112	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP26A1—esophageal cancer	4.31e-05	0.000111	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.28e-05	0.000111	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP26A1—esophageal cancer	4.22e-05	0.000109	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP26A1—esophageal cancer	4.21e-05	0.000109	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GSTT1—esophageal cancer	4.2e-05	0.000109	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALOX15—esophageal cancer	4.2e-05	0.000109	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CA2—esophageal cancer	4.19e-05	0.000108	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP2A6—esophageal cancer	4.15e-05	0.000107	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—EP300—esophageal cancer	4.15e-05	0.000107	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALOX15—esophageal cancer	4.11e-05	0.000106	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ALDH2—esophageal cancer	4.11e-05	0.000106	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALOX15—esophageal cancer	4.1e-05	0.000106	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTO1—esophageal cancer	4.01e-05	0.000104	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TPI1—esophageal cancer	4.01e-05	0.000104	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	4e-05	0.000103	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTGS1—esophageal cancer	3.94e-05	0.000102	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ENO1—esophageal cancer	3.94e-05	0.000102	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTO1—esophageal cancer	3.92e-05	0.000101	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TPI1—esophageal cancer	3.92e-05	0.000101	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TPI1—esophageal cancer	3.92e-05	0.000101	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTO1—esophageal cancer	3.92e-05	0.000101	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTT1—esophageal cancer	3.91e-05	0.000101	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ADH7—esophageal cancer	3.9e-05	0.000101	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PLCE1—esophageal cancer	3.9e-05	0.000101	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PSME2—esophageal cancer	3.88e-05	0.0001	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PSME1—esophageal cancer	3.88e-05	0.0001	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.87e-05	0.0001	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP2A6—esophageal cancer	3.86e-05	9.99e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALDOB—esophageal cancer	3.84e-05	9.93e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CREBBP—esophageal cancer	3.81e-05	9.86e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALDOB—esophageal cancer	3.76e-05	9.73e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALDOB—esophageal cancer	3.75e-05	9.71e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GAPDH—esophageal cancer	3.7e-05	9.56e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.68e-05	9.51e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CRABP1—esophageal cancer	3.66e-05	9.47e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ENO1—esophageal cancer	3.66e-05	9.47e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTGS1—esophageal cancer	3.66e-05	9.47e-05	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.66e-05	9.46e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GAPDH—esophageal cancer	3.62e-05	9.36e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GAPDH—esophageal cancer	3.61e-05	9.34e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PSME2—esophageal cancer	3.61e-05	9.33e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PSME1—esophageal cancer	3.61e-05	9.33e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CRABP1—esophageal cancer	3.59e-05	9.28e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CRABP1—esophageal cancer	3.58e-05	9.26e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GNG7—esophageal cancer	3.49e-05	9.01e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ADH1B—esophageal cancer	3.42e-05	8.84e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—NOS3—esophageal cancer	3.41e-05	8.83e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GNG7—esophageal cancer	3.41e-05	8.83e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GNG7—esophageal cancer	3.41e-05	8.81e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP1B1—esophageal cancer	3.35e-05	8.65e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.34e-05	8.65e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—BLVRB—esophageal cancer	3.32e-05	8.59e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SLC52A3—esophageal cancer	3.32e-05	8.59e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TYMP—esophageal cancer	3.27e-05	8.45e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALDH2—esophageal cancer	3.27e-05	8.44e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	3.21e-05	8.29e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALDH2—esophageal cancer	3.2e-05	8.27e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALDH2—esophageal cancer	3.19e-05	8.25e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP26A1—esophageal cancer	3.18e-05	8.22e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CYP19A1—esophageal cancer	3.15e-05	8.14e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	3.14e-05	8.11e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PTGS2—esophageal cancer	3.12e-05	8.07e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP1B1—esophageal cancer	3.11e-05	8.05e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTT1—esophageal cancer	3.11e-05	8.03e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALOX15—esophageal cancer	3.1e-05	8.01e-05	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—PIK3CA—esophageal cancer	3.07e-05	7.94e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP2A6—esophageal cancer	3.07e-05	7.94e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTT1—esophageal cancer	3.04e-05	7.87e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTT1—esophageal cancer	3.04e-05	7.85e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP2A6—esophageal cancer	3.01e-05	7.78e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP2A6—esophageal cancer	3e-05	7.76e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTO1—esophageal cancer	2.95e-05	7.64e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TPI1—esophageal cancer	2.95e-05	7.64e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP19A1—esophageal cancer	2.93e-05	7.57e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ENO1—esophageal cancer	2.91e-05	7.53e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTGS1—esophageal cancer	2.91e-05	7.53e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—HMOX1—esophageal cancer	2.87e-05	7.42e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PSME1—esophageal cancer	2.87e-05	7.42e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PSME2—esophageal cancer	2.87e-05	7.42e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ENO1—esophageal cancer	2.85e-05	7.37e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTGS1—esophageal cancer	2.85e-05	7.37e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTGS1—esophageal cancer	2.85e-05	7.36e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ENO1—esophageal cancer	2.85e-05	7.36e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALDOB—esophageal cancer	2.83e-05	7.32e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.83e-05	7.3e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CA1—esophageal cancer	2.83e-05	7.3e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PSME1—esophageal cancer	2.81e-05	7.26e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PSME2—esophageal cancer	2.81e-05	7.26e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PSME1—esophageal cancer	2.8e-05	7.25e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PSME2—esophageal cancer	2.8e-05	7.25e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ABCB1—esophageal cancer	2.76e-05	7.13e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GAPDH—esophageal cancer	2.73e-05	7.05e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.72e-05	7.04e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CRABP1—esophageal cancer	2.7e-05	6.99e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—HMOX1—esophageal cancer	2.67e-05	6.91e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.63e-05	6.81e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—EP300—esophageal cancer	2.6e-05	6.71e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CA2—esophageal cancer	2.58e-05	6.68e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GNG7—esophageal cancer	2.57e-05	6.65e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ABCB1—esophageal cancer	2.56e-05	6.63e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP1B1—esophageal cancer	2.48e-05	6.4e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP1B1—esophageal cancer	2.42e-05	6.27e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP1B1—esophageal cancer	2.42e-05	6.25e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALDH2—esophageal cancer	2.41e-05	6.23e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.4e-05	6.21e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ADH7—esophageal cancer	2.4e-05	6.21e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP19A1—esophageal cancer	2.33e-05	6.02e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTT1—esophageal cancer	2.29e-05	5.92e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP19A1—esophageal cancer	2.28e-05	5.89e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP19A1—esophageal cancer	2.27e-05	5.88e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP2A6—esophageal cancer	2.26e-05	5.86e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ENO1—esophageal cancer	2.15e-05	5.55e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTGS1—esophageal cancer	2.15e-05	5.55e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.15e-05	5.55e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—HMOX1—esophageal cancer	2.12e-05	5.49e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PSME1—esophageal cancer	2.12e-05	5.47e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PSME2—esophageal cancer	2.12e-05	5.47e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.11e-05	5.45e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—HMOX1—esophageal cancer	2.08e-05	5.38e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—HMOX1—esophageal cancer	2.08e-05	5.37e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ABCB1—esophageal cancer	2.04e-05	5.27e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TYMP—esophageal cancer	2.01e-05	5.2e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ABCB1—esophageal cancer	2e-05	5.16e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ABCB1—esophageal cancer	1.99e-05	5.15e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.96e-05	5.06e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CA—esophageal cancer	1.92e-05	4.97e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.91e-05	4.93e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CREBBP—esophageal cancer	1.84e-05	4.76e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.83e-05	4.72e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.82e-05	4.71e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TPI1—esophageal cancer	1.82e-05	4.71e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.75e-05	4.51e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.72e-05	4.44e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CREBBP—esophageal cancer	1.71e-05	4.43e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.68e-05	4.34e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.67e-05	4.3e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—NOS3—esophageal cancer	1.65e-05	4.26e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GNG7—esophageal cancer	1.58e-05	4.09e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HMOX1—esophageal cancer	1.57e-05	4.05e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—NOS3—esophageal cancer	1.53e-05	3.97e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTGS2—esophageal cancer	1.51e-05	3.9e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.48e-05	3.84e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.41e-05	3.65e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTGS2—esophageal cancer	1.4e-05	3.63e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.4e-05	3.61e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CREBBP—esophageal cancer	1.36e-05	3.52e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CREBBP—esophageal cancer	1.33e-05	3.45e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.33e-05	3.44e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ENO1—esophageal cancer	1.32e-05	3.42e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.32e-05	3.42e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PSME2—esophageal cancer	1.3e-05	3.37e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PSME1—esophageal cancer	1.3e-05	3.37e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—EP300—esophageal cancer	1.25e-05	3.24e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NOS3—esophageal cancer	1.22e-05	3.15e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NOS3—esophageal cancer	1.19e-05	3.09e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NOS3—esophageal cancer	1.19e-05	3.08e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—EP300—esophageal cancer	1.17e-05	3.02e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.12e-05	2.91e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTGS2—esophageal cancer	1.12e-05	2.88e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTGS2—esophageal cancer	1.09e-05	2.82e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.09e-05	2.82e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.06e-05	2.73e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CREBBP—esophageal cancer	1e-05	2.6e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HMOX1—esophageal cancer	9.65e-06	2.49e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CA—esophageal cancer	9.28e-06	2.4e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—EP300—esophageal cancer	9.28e-06	2.4e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ABCB1—esophageal cancer	9.26e-06	2.39e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—EP300—esophageal cancer	9.09e-06	2.35e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—EP300—esophageal cancer	9.07e-06	2.34e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NOS3—esophageal cancer	9e-06	2.33e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CA—esophageal cancer	8.64e-06	2.23e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTGS2—esophageal cancer	8.23e-06	2.13e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CA—esophageal cancer	6.86e-06	1.77e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—EP300—esophageal cancer	6.84e-06	1.77e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CA—esophageal cancer	6.72e-06	1.74e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CA—esophageal cancer	6.71e-06	1.73e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CREBBP—esophageal cancer	6.19e-06	1.6e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NOS3—esophageal cancer	5.54e-06	1.43e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTGS2—esophageal cancer	5.07e-06	1.31e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CA—esophageal cancer	5.06e-06	1.31e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—EP300—esophageal cancer	4.22e-06	1.09e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CA—esophageal cancer	3.12e-06	8.06e-06	CbGpPWpGaD
